Mutation patterns in receptor tyrosine kinase (RTK) genes, specifically KIT and FLT3, vary between adult and pediatric patients with inv(16)(p13q22) AML, a distinction not observed in those with t(8;21) AML. The gene discussed is FLT3; the disease is acute myeloid leukemia.